Real-time enrollment status for this attention-deficit/hyperactivity disorder clinical trial
Current Status
Recruiting
Checked: September 15, 2026 at 1:11 AM UTC
| NCT Number | NCT07759154 |
| Recruiting Status | Recruiting |
| Condition | Attention-deficit/Hyperactivity Disorder |
| Phase | PHASE3 |
| Target Enrollment | 80 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | September 14, 2026 (Yesterday) |
As of September 15, 2026: Clinical trial NCT07759154 is currently recruiting participants. This phase3 study for attention-deficit/hyperactivity disorder is actively seeking new participants at 16 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07759154 is actively recruiting participants as of September 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07759154 was last updated Yesterday (September 14, 2026). HelloStudys verifies this status automatically.